Immuneering IMRX Ratios (2020-2026)

NASDAQ IMRX
$4.13 -0.03 (-0.72%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Immuneering Quarterly Ratios

Periods 25 quarters
Latest Jun 2026

Immuneering ratios data for the quarter ended Jun 2026. These financial ratios cover 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
54.56%-8.77%50.55%49.23%49.60%100.00%
EBT Margin
-1,768.40%-5,787.65%-6,964.23%-12,183.19%-33,781.04%-2,960,184.40%
EBIT Margin
-1,772.01%-5,863.02%-7,036.37%-12,334.43%-34,362.04%-3,073,627.91%
EBITDA Margin
-1,769.52%-5,855.20%-7,005.99%-12,268.90%-34,165.60%-3,055,127.25%
Operating Margin
-1,772.01%-5,863.02%-7,036.37%-12,334.43%-34,362.04%-3,073,627.91%
Net Margin
-1,770.08%-5,688.22%-7,020.42%-12,208.67%-33,466.21%-2,911,112.31%
FCF Margin
-1,876.25%-4,880.00%-6,748.08%-10,182.56%-28,701.08%-2,597,344.18%
Efficiency
Assets AverageAssets Avg.
108.54M165.37M159.58M147.25M137.87M128.03M115.03M116.30M119.39M108.23M95.28M82.54M72.82M60.64M51.70M45.37M140.56M236.52M223.40M208.43M
Equity AverageEquity Avg.
61.55M157.14M150.02M138.83M127.74M115.87M103.82M106.45M109.56M97.30M84.65M72.51M62.01M49.55M41.61M35.39M128.46M223.23M212.50M198.63M
Asset Utilization RatioAsset Util.
0.020.010.010.010.000.000.000.000.00
Valuation
Price to SalesP/S
189.99105.83112.64150.32747.13404.260.00M0.01M0.49M
Price to BookP/B
3.071.411.181.073.101.172.632.582.162.381.090.571.341.651.314.191.221.331.651.69
Enterprise Value
336.02M70.92M32.93M14.68M260.92M22.61M165.74M187.74M127.54M129.48M14.42M-21.77M26.66M32.17M18.83M94.92M50.13M116.77M184.22M172.94M
Market Capitalization
485.50M220.12M170.70M142.78M378.12M128.13M257.27M296.73M224.79M215.15M85.70M37.96M77.32M68.31M54.70M121.28M277.69M289.60M340.91M322.84M
Return Ratios
Return on Sales [ROS]ROS
-1,772.01%-5,863.02%-7,036.37%-12,334.43%-34,362.04%-3,073,627.91%-40,147.97%-142,545.95%-12,328,770.77%
Return on Capital Employed [ROCE]ROCE
-27.70%-21.21%-26.03%-30.83%-37.42%-43.13%-48.85%-49.95%-49.31%-58.19%-65.54%-79.82%-93.80%-120.59%-137.86%-169.14%-48.99%-26.22%-27.12%-31.68%
Return on Assets [ROA]ROA
-26.33%-20.39%-25.24%-29.74%-34.99%-39.62%-45.02%-45.25%-44.16%-50.64%-58.22%-69.34%-80.86%-101.39%-119.93%-137.43%-44.53%-23.82%-24.74%-28.19%
Return on Equity [ROE]ROE
-46.43%-21.46%-26.85%-31.55%-37.76%-43.78%-49.88%-49.43%-48.13%-56.33%-65.54%-78.92%-94.95%-124.06%-148.99%-176.18%-48.72%-25.24%-26.01%-29.58%

Immuneering Ratios API

Pull Immuneering's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IMRX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY